AUROPHARMA.BOAUROPHARMA.BO
LOADING
|||
Operating Income Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year operating income growth rate
Latest
-63.27%
↓ 560% below average
Average (39q)
13.76%
Historical baseline
Range
High:478.01%
Low:-404.38%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2025 | -63.27% |
| Q2 2025 | 116.48% |
| Q1 2025 | -55.53% |
| Q4 2024 | 1.59% |
| Q3 2024 | 1.58% |
| Q2 2024 | 133.24% |
| Q1 2024 | -54.31% |
| Q4 2023 | 6.07% |
| Q3 2023 | 10.35% |
| Q2 2023 | 263.38% |
| Q1 2023 | -65.09% |
| Q4 2022 | -6.09% |
| Q3 2022 | 6.66% |
| Q2 2022 | 478.01% |
| Q1 2022 | -81.29% |
| Q4 2021 | -8.37% |
| Q3 2021 | 3.35% |
| Q2 2021 | 161.48% |
| Q1 2021 | -68.03% |
| Q4 2020 | -4.79% |
| Q3 2020 | 11.51% |
| Q2 2020 | 67.04% |
| Q1 2020 | -37.61% |
| Q4 2019 | 2.10% |
| Q3 2019 | 5.13% |
| Q2 2019 | 151.22% |
| Q1 2019 | -57.50% |
| Q4 2018 | 6.57% |
| Q3 2018 | 6.83% |
| Q2 2018 | 133.55% |
| Q1 2018 | -62.67% |
| Q4 2017 | -7.21% |
| Q3 2017 | 26.08% |
| Q2 2017 | 171.80% |
| Q1 2017 | -404.38% |
| Q4 2016 | -4.31% |
| Q3 2016 | 4.64% |
| Q2 2016 | 138.33% |
| Q1 2016 | -382.21% |
| Q4 2015 | 5.96% |